Found: 43
Select item for more details and to access through your institution.
Circulating Endothelial Cell Levels Correlate with Treatment Outcomes of Splanchnic Vein Thrombosis in Patients with Chronic Myeloproliferative Neoplasms.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 3, p. 364, doi. 10.3390/jpm12030364
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13332, doi. 10.3390/ijms232113332
- By:
- Publication type:
- Article
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 2150, doi. 10.3390/ijms22042150
- By:
- Publication type:
- Article
Clinical and biological data on the use of hydroxychloroquine against SARS‐CoV‐2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 124, doi. 10.1002/jmv.26217
- By:
- Publication type:
- Article
Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.892331
- By:
- Publication type:
- Article
How I Manage Chronic Lymphocytic Leukemia.
- Published in:
- Hematology Reports, 2023, v. 15, n. 3, p. 454, doi. 10.3390/hematolrep15030047
- By:
- Publication type:
- Article
Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 335, doi. 10.1111/bjh.16335
- By:
- Publication type:
- Article
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 819, doi. 10.1111/bjh.15039
- By:
- Publication type:
- Article
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 548, doi. 10.1007/s10637-019-00769-5
- By:
- Publication type:
- Article
Hydroxychloroquine as Prophylaxis for COVID-19: A Review.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.605185
- By:
- Publication type:
- Article
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11 , 7162.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7162, doi. 10.3390/jcm11237162
- By:
- Publication type:
- Article
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67906-w
- By:
- Publication type:
- Article
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 207, doi. 10.3390/cancers14010207
- By:
- Publication type:
- Article
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4566, doi. 10.3390/cancers13184566
- By:
- Publication type:
- Article
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2639, doi. 10.3390/cancers13112639
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 291, doi. 10.3390/cancers13020291
- By:
- Publication type:
- Article
Predictive Role of Positron Emission Tomography in the Outcome of Patients with Follicular Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 4, p. 291
- By:
- Publication type:
- Article
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.740079
- By:
- Publication type:
- Article
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 10, p. 2190
- By:
- Publication type:
- Article
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma.
- Published in:
- Histopathology, 2017, v. 71, n. 1, p. 72, doi. 10.1111/his.13189
- By:
- Publication type:
- Article
Acalabrutinib vs Rituximab plus Idelalisib or Bendamustine by Investigator Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 498
- By:
- Publication type:
- Article
Characterization of Duvelisib in Patients with Refractory Marginal Zone Lymphoma: Data from the Phase 2 DYNAMO Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S312, doi. 10.1016/j.clml.2019.07.283
- By:
- Publication type:
- Article
Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S280, doi. 10.1016/j.clml.2019.07.217
- By:
- Publication type:
- Article
Pheochromocytoma mimicking a non-ST elevation acute myocardial infarction.
- Published in:
- Cardiology Journal, 2009, v. 16, n. 4, p. 355
- By:
- Publication type:
- Article
Acalabrutinib vs. Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia: ASCEND Results at ~4 Years of Follow-up.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 33
- By:
- Publication type:
- Article
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0590-1
- By:
- Publication type:
- Article
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 655, doi. 10.1002/hon.3184
- By:
- Publication type:
- Article
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prolonged <sup>18</sup>FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G).
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 1, p. 79, doi. 10.1002/ajh.21869
- By:
- Publication type:
- Article
Acalabrutinib vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 11, p. 437
- By:
- Publication type:
- Article
Immunophenotype and Intermediate-High International Prognostic Index Score Are Prognostic Factors for Therapy in Diffuse Large B-Cell Lymphoma Patients.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 24, p. 5667, doi. 10.1002/cncr.25307
- By:
- Publication type:
- Article
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Lenalidomide in Pretreated Patients with Diffuse Large B‐Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1246, doi. 10.1634/theoncologist.2018-0603
- By:
- Publication type:
- Article
Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 1, p. 59, doi. 10.1001/jama.2010.1919
- By:
- Publication type:
- Article
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 3, p. 259, doi. 10.1159/000509923
- By:
- Publication type:
- Article
Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- Cell Biology & Toxicology, 2023, v. 39, n. 3, p. 795, doi. 10.1007/s10565-021-09640-x
- By:
- Publication type:
- Article
End of induction [<sup>18</sup>F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 11, p. 3311, doi. 10.1007/s00259-024-06765-z
- By:
- Publication type:
- Article
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells.
- Published in:
- Oncology Reports, 2020, v. 44, n. 4, p. 1561
- By:
- Publication type:
- Article